Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy.
Rao, Nanyan
Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy. [electronic resource] - Chemotherapy 2017 - 246-255 p. digital
Publication Type: Journal Article
1421-9794
10.1159/000470900 doi
Adult
Anthracyclines--therapeutic use
Antigens, Neoplasm--metabolism
Antineoplastic Agents--therapeutic use
Bridged-Ring Compounds--therapeutic use
CD4-Positive T-Lymphocytes--cytology
CD8-Positive T-Lymphocytes--cytology
DNA Topoisomerases, Type II--metabolism
DNA-Binding Proteins--metabolism
Disease-Free Survival
Drug Therapy, Combination
Female
Humans
Ki-67 Antigen--metabolism
Linear Models
Lymphocytes, Tumor-Infiltrating--cytology
Middle Aged
Neoadjuvant Therapy
Remission Induction
Survival Rate
Taxoids--therapeutic use
Triple Negative Breast Neoplasms--drug therapy
Tumor Suppressor Protein p53--metabolism
Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy. [electronic resource] - Chemotherapy 2017 - 246-255 p. digital
Publication Type: Journal Article
1421-9794
10.1159/000470900 doi
Adult
Anthracyclines--therapeutic use
Antigens, Neoplasm--metabolism
Antineoplastic Agents--therapeutic use
Bridged-Ring Compounds--therapeutic use
CD4-Positive T-Lymphocytes--cytology
CD8-Positive T-Lymphocytes--cytology
DNA Topoisomerases, Type II--metabolism
DNA-Binding Proteins--metabolism
Disease-Free Survival
Drug Therapy, Combination
Female
Humans
Ki-67 Antigen--metabolism
Linear Models
Lymphocytes, Tumor-Infiltrating--cytology
Middle Aged
Neoadjuvant Therapy
Remission Induction
Survival Rate
Taxoids--therapeutic use
Triple Negative Breast Neoplasms--drug therapy
Tumor Suppressor Protein p53--metabolism